Helen Whitehead

Helen Whitehead is a proactive regulatory professional with over 20 years of drug development experience. They held roles at Biogen Idec from 2007 to 2012 as a Senior Regulatory Manager and have been an Associate Director since 2012. Currently, they serve as Senior Director, Global Regulatory Portfolio Lead at Biogen, demonstrating a successful history in establishing and executing regulatory strategies across multiple therapeutic areas, including neurology and immunology. Previously, Helen worked at GlaxoSmithKline and Johnson & Johnson in various regulatory affairs roles. Helen is recognized for their leadership, mentorship, and ability to thrive under pressure.